On-demand webinars
Learn on demand by accessing past events and meeting highlights whenever, wherever.
Listen to Dr Matthew Wilson describe the treatment pathway in sALCL to gain valuable insights that can be translated into your own clinical practice.
Dr Wilson presents key efficacy and safety data from the ECHELON-2 study,1 which investigated the use of ADCETRIS® + CHP as a treatment option for previously untreated adult patients with sALCL. Dr Wilson also shares his experience using ADCETRIS through real-world case studies.
Listen to Dr Andrew Charlton discuss the importance of considering re-treatment of multiple myeloma patients with lenalidomide-based therapies beyond the front-line setting , where they may have been exposed to but not refractory to lenalidomide. Andrew Charlton also discusses the background and some supporting evidence for the two commonly used front-line lenalidomide-based regimens in the UK: front-line therapy in non-transplant eligible patients, in combination with dexamethasone and in a maintenance role in post-ASCT patients.